EUVIMEDEUVIMED entdecken
Crossref

Dihydropyrazine activates the CAMKK2-AMPK-ULK1 signaling pathway in human hepatoma HepG2 cells

Madoka Sawai, Yuu Miyauchi, Hisao Kansui, Shinji Takechi

The Journal of Toxicological Sciences · 2025

DOI: 10.2131/jts.50.577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Toxicological Sciences, 2025. Verfasst von Madoka Sawai und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy at Fukuoka, International University of Health and Welfare. Hauptthemen laut MEDLINE: Autophagy-Related Protein-1 Homolog, Calcium-Calmodulin-Dependent Protein Kinase Kinase, AMP-Activated Protein Kinases, Signal Transduction. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autophagy-Related Protein-1 HomologCalcium-Calmodulin-Dependent Protein Kinase KinaseAMP-Activated Protein KinasesSignal TransductionIntracellular Signaling Peptides and ProteinsPyrazinesCarcinoma, HepatocellularLiver NeoplasmsHumansHep G2 CellsAutophagyPhosphorylationEndoplasmic Reticulum StressAMP-Activated Protein Kinase Kinases

Stichwörter der Autor:innen

AutophagyDihydropyrazineER stressGlycationHepG2 cells

Substanzen

Autophagy-Related Protein-1 HomologCalcium-Calmodulin-Dependent Protein Kinase KinaseCAMKK2 protein, humanAMP-Activated Protein KinasesULK1 protein, humanIntracellular Signaling Peptides and ProteinsPyrazinesSTK11 protein, humanAMP-Activated Protein Kinase Kinases

Autor:innen und Institutionen

  • School of Pharmacy at Fukuoka, International University of Health and Welfare.
  • Faculty of Pharmaceutical Sciences, Sojo University.

Zitieren

APA

Sawai, M., Miyauchi, Y., Kansui, H., & Takechi, S. (2025). Dihydropyrazine activates the CAMKK2-AMPK-ULK1 signaling pathway in human hepatoma HepG2 cells. The Journal of Toxicological Sciences. https://doi.org/10.2131/jts.50.577

Vancouver

Sawai M, Miyauchi Y, Kansui H, Takechi S. Dihydropyrazine activates the CAMKK2-AMPK-ULK1 signaling pathway in human hepatoma HepG2 cells. The Journal of Toxicological Sciences. 2025. doi:10.2131/jts.50.577

BibTeX
@article{Sawai2025,
  author = {Sawai, Madoka and Miyauchi, Yuu and Kansui, Hisao and Takechi, Shinji},
  title = {Dihydropyrazine activates the CAMKK2-AMPK-ULK1 signaling pathway in human hepatoma HepG2 cells},
  journal = {The Journal of Toxicological Sciences},
  year = {2025},
  doi = {10.2131/jts.50.577}
}
Kostenlos starten →